Live Pharmaceutical Import data of Vietnam imports from india under HS Code 293979 via Port Cchq-express-delivery , our Vietnam customs import data reports include date, value, quantity, product description, HS code, port, country, and Vietnam pharmaceutical importers data
| Date |
HS Code |
Product Description |
Origin Country |
Custom Name |
QTY. |
Unit |
Value($) |
Importer Name |
|---|---|---|---|---|---|---|---|---|
| 2024-04-03 00:00:00 |
29397900
|
Raw materials used in the pharmaceutical industry: Ivabradine Hydrochloride, used in testing, manufacturer: BIOCON LIMITED, 100% new | India | CCHQ Express Delivery | 0.1 | GRM | 1.5 | Importer Name |
2024-04-03 00:00:00
Raw materials used in the pharmaceutical industry: Ivabradine Hydrochloride, used in testing, manufacturer: BIOCON LIMITED, 100% new
0.1
GRM
1.5
The database includes shipment-level information such as shipment date, HS code, product description, quantity, value, port details, country of origin & destination, & importer-exporter information for accurate trade analysis of products under HS code 293979 for Vietnam pharmaceutical imports from Thailand via Port Cchq-express-delivery.
Port Cchq-express-delivery typically refers to a port that is used for handling and forwarding shipments into Vietnam, making it important for tracking inland and cross-border trade flows.
It helps businesses understand sourcing patterns, evaluate supplier performance, track pricing trends, and identify demand for pharmaceutical products, enabling better decision-making for trade and market expansion for Vietnam pharmaceutical imports from india under HS code 293979 via Port Cchq-express-delivery.
Businesses can identify key importers, evaluate supplier competitiveness, track pricing trends, and analyze demand for specific rubber products to make strategic sourcing and expansion decisions.
Importers, exporters, traders, manufacturers, and market analysts can use this data to understand trade patterns, optimize supply chains, identify potential partners, and gain a competitive advantage in the pharmaceutical market.
